Beacon Therapeutics vs GenSight Biologics

Beacon Therapeutics logo

Beacon Therapeutics

Transforming Vision, Transforming Lives

95 employees · est. 2023 · London, United Kingdom

VS
GenSight Biologics logo

GenSight Biologics

Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases

34 employees · est. 2013 · Paris, France

GenSight Biologics is the older company (2023 vs 2013); Beacon Therapeutics is the larger of the two.

Side-by-Side Comparison

Beacon Therapeutics GenSight Biologics
Founded
2023 2013 older
Headquarters
London, United Kingdom Paris, France
Employees
95 larger 34
Industry
Biotechnology, Health Care, Health and Wellness Biotechnology, Health Care
Funding Stage
Series C Post-IPO Equity
Total Funding
$341.00M $245.64M
Funding Rounds
4 17
Taxonomy
Ophthalmic Gene TherapyRetinal DiseasesX-linked Retinitis PigmentosaAMD (age-related Macular Degeneration)Cone-rod DystrophyGene Therapy Program +8 Clinical-stage BiotechGene TherapyRetinal DiseasesNeurodegenerative DiseasesMitochondrial Targeting SequenceOptogenetics +8
Website
beacontx.com gensight-biologics.com
Beacon Therapeutics logo

About Beacon Therapeutics

Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases leading to blindness. The company's scientific foundation encompasses a late-stage development candidate...

GenSight Biologics logo

About GenSight Biologics

GenSight Biologics is a biotechnology startup focused on developing groundbreaking therapies for severe retinal neurodegenerative diseases. Leveraging the Mitochondrial Targeting Sequence (MTS) and optogenetics, the company is striving to preserve or restore vision in patients with degenerative reti...

Also comparing in this category

We will tell you when either one moves

BounceWatch watches Beacon Therapeutics and GenSight Biologics for new funding, fast hiring, new executives and a change of software vendor. When one happens, it is in your next e-mail.

Get notified when Beacon Therapeutics or GenSight Biologics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

Frequently Asked Questions

Beacon Therapeutics was founded in 2023, based in London, United Kingdom, with 95 employees. Beacon Therapeutics is a United States based ophthalmic gene therapy company that aims to restore and enhance the sight of patients suffering from a variety of prevalent and rare retinal diseases lead. GenSight Biologics was founded in 2013, based in Paris, France, with 34 employees. GenSight Biologics is a biotechnology startup focused on developing groundbreaking therapies for severe retinal neurodegenerative diseases. Leveraging the Mitochondrial Targeting Sequence (MTS) and op.
Beacon Therapeutics has raised $341.00M and GenSight Biologics $245.64M. Latest stage: Beacon Therapeutics Series C, GenSight Biologics Post-IPO Equity.
Both work in Biotechnology and Health Care and list retinal diseases and vision restoration among their focus areas.

Compare Beacon Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Beacon Therapeutics on 9 Jun 2026, and GenSight Biologics on 11 Jun 2025. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes